Actual enrollment decreased by 958 participants
Before: 2648 participants (actual). After: 1690 participants (actual).
Study sponsor: Spero Therapeutics
Primary completion is the date data collection ends for the main study measures, not when results are published.
Before: 2648 participants (actual). After: 1690 participants (actual).
Text changed; whether the study measures changed has not been verified. Saved text may be shortened.
Before: Measure: Number of Participants With Overall Response at the Test-of-Cure (TOC) Visit. After: Measure: Number of Participants With Overall Response at the Test-of-Cure (TOC) Visit in the Microbiological Intent-to-Treat (Micro-ITT) Population.
Before: 1690 participants (actual). After: 2648 participants (actual).
Before: 18 Jan 2025. After: 27 Jan 2025.